Reishi mushroom
Best for
Break the insomnia cycle
Promising early signal · 3000 mg/day for 4 weeks · 1 study , n=48
9 papers · 2 claims · 59 outcomes scored · 2 positive
Outcomes
What reishi mushroom actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Quiets the nervous-system overdrive that keeps you wired at bedtime.
Gives your cells more fuel when treatment is draining everything you have.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Break the insomnia cycle Promising early signal | | 1 RCT n=48 | 3000 mg | 4 wk | #7/14 |
| Ease fatigue during cancer care Faint early signal | | 1 RCT n=48 | 3000 mg | 4 wk | #1/5 |
Risk profile
Adverse events and known drug interactions
Safety events
Drug interactions
Sources
- 1. A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Reishi Mushroom (Ganoderma lucidum), Stinging Nettle (Urtica dioica), and Epimedium (Epimedium sagittatum). (2021) ↑
- 2. Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. (2012) ↑
- 3. Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers. (2017) ↑
- 4. Clinical Evaluation of Ganoderma lucidum Spore Oil for Triglyceride Reduction: A Randomized, Double-Blind, Crossover Study. (2025) ↑
- 5. Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study. (2018) ↑
- 6. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. (2015) ↑
- 7. Ganoderma lucidum (Reishi mushroom) for cancer treatment. (2016) ↑
- 8. Coriolus Versicolor and Ganoderma Lucidum Related Natural Products as an Adjunct Therapy for Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2019) ↑
- 9. Evaluation of Immune Modulation by β-1,3; 1,6 D-Glucan Derived from Ganoderma lucidum in Healthy Adult Volunteers, A Randomized Controlled Trial. (2023) ↑
Generated August 14, 2026
Related
More evidence for Reishi mushroom
Evidence guide
Reishi (Ganoderma lucidum, lingzhi)
NewBitter, Bright, and Patient: When Reishi's 2,000-Year Myth Meets 12-Week Science
Evidence guide
Apr 28, 2026
Evidence map
Sleep
NewSleep: evidence map across 37 supplements
Evidence coverage map
Jul 30, 2026
Ingredient evidence
Ingredient evidence
NewCaffeine
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewCarnitine
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewCoffee
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewCoQ10
All scored outcomes
Aug 14, 2026